1 / 5

Allergy Shots Market To Sail Through Micros At A CAGR Of 6% Between 2020-2030

According to a latest report published by the PMR, the global allergy shots market is projected to be valued at US$ 1.5 Bn in 2020, and is expected to expand at a CAGR of around 6% during the forecast period (2020u20132030).

Télécharger la présentation

Allergy Shots Market To Sail Through Micros At A CAGR Of 6% Between 2020-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Allergy Shots Market Report Id : PMRREP31924 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved

  2. About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com

  3. The Allergy Shots Market To Sail Through Micros At A CAGR Of 6% Between 2020-2030 The healthcare vertical, which was a physical interaction-based arm, has started shifting to virtual consultation at large. This has, in turn, helped in transcending the geographical barriers. As such, interoperable platforms are being supported by behavioral research, backed by real-time care interventions and personalized medications. The Allergy Shots Market would be moving forward with these additions. Allergy shots, also known as allergy immunotherapies, including subcutaneous immunotherapy, sublingual immunotherapy, and oral therapies, is a long-term treatment that helps reduce allergic reactions. The most common type of allergy includes allergic rhinitis/hay fever, which accounts for 43% of the cases. According to a latest report published by the PMR, the global allergy shots market is projected to be valued at US$ 1.5 Bn in 2020, and is expected to expand at a CAGR of around 6% during the forecast period (2020–2030). Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/31924

  4. Key Takeaways from Allergy Shots Market Study • Injections is the leading segment by product in the global allergy shots market. The sublingual immunotherapy (SLIT) segment has been gaining more traction in recent years, and is expected to expand by 6.5% during the forecast period. • Europe is the leading market for allergy shots, followed by the U.S. • The South Asian region, including India and ASEAN countries, is the fastest-growing allergy shots market, due to improving medical infrastructure. • ALK Abello is the leading player in the global allergy shots market. The company invests most of its revenue in R&D, and thus, holds a strong pipeline, especially in the SLIT segment. • 100+ health systems are partnering with retail chains, providing physician oversights and increased patient traffic to retail clinics, and extending health system networks to new patient populations. • The COVID-19 pandemic has led to postponement of non-essential treatment in hospitals and clinics, which will impede market growth in the short term. • “Increasing corporate agreements and strong product pipeline will boost the global allergy shots market,” says a PMR analyst. Access Full Report @ https://www.persistencemarketresearch.com/checkout/31924

More Related